Senator Ted Cruz, concerned that the state of R-Texas, its states, and others are approaching a government-produced deficit, has enacted a law to remove federal barriers to the purchase of coronavirus treatments.
“For several months, many of us have been concerned that the Biden administration has taken over the federal distribution of monoclonal antibody treatments,” Cruz said in a statement to Acesparks Digital on Wednesday.
“The bill I have introduced will allow states to determine their needs, so that those who are currently facing severe shortages due to the Biden administration’s misguided policies can ensure that their citizens receive the help they need. President Biden has finally acknowledged this. , not the federal government, responds in situations like this, and my bill is the first step in that direction. “
RON DESANTIS BAYDEN DIVIDED ADMIN TO STATE TO PURCHASE MONOCLONAL ANTIQUES TREATMENTS
Presented on Tuesday account To protect state power, it amended the 1950 Defense Manufacturing Act and the Food, Drug and Cosmetics Act. It also allows states to direct federal funds to “materials that a state, region, or possession could not purchase due to a call from the Department of Defense prior to the effective date of this Act to combat the COVID-19 epidemic.” Production Law of 1950. “
Cruise legislation adds to growing opposition from Republicans to the federal government’s September decision to control the spread of monoclonal antibody therapists.
Formerly an administrative officer described the resolution as a way to “help maintain a geographically and temporally equal distribution across the country – providing states and regions with a consistent, fairly distributed supply in the coming weeks”.
But politicians in states like Florida have criticized the effectiveness of this approach.
IN FLORIDA GENERAL KHURRGON BAYDEN ADMIN ‘ACTIVATELY PREVENTS’ TREATMENT OF MONOCLONAL ANTIQUES.
Florida Gov. Ron DeSantis held a news conference Monday, urging the administration to allow direct purchases by states. Last week, its chief surgeon told the Department of Health and Human Services (HHS) that “treatment of monoclonal antibodies in the United States will effectively prevent the spread of the disease.”
In Texas, the state Department of Health said it has “run out” of monoclonal antibody reserves in many places.
“The federal government controls the spread of monoclonal antibodies, and regional infusion centers in Austin, Elsa, Fort Worth, San Antonio, and Woodland have stopped delivering sotrovimab, an effective monoclonal antibody against the COVID-19 omicron variant. From federal government to national shortage.” December 27 The statement was read.
“They won’t be able to offer it until the federal government sends additional courses of sotrovimab to Texas in January.”
RUBIO CORONAVIRUS Many said the “real crisis” around them was “irrational hysteria.”
Last week, HHS announced the administration’s success in bringing two new over-the-counter COVID-19 tests to the market – a broader effort by the administration to increase access to the tests.
Biden has been criticized for saying there was no federal solution to the epidemic, despite the executive’s many initiatives. Following the statement, the White House administration announced on Twitter that it was providing medical personnel, equipment and other assistance to the states.
In December, the White House announced the deployment of federal staff to help dozens of states.
“As we face the potential of the new option and the increasing number of cases during the winter months, today the president makes it clear that the federal government is ready to help once again,” the White House said Dec. 2.